New study explores safer cancer surgery for liver patients

NCT ID NCT07368309

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study examined how to best manage early-stage upper gastrointestinal cancer in patients who also have liver cirrhosis and enlarged veins in the esophagus (varices). Researchers compared outcomes of a keyhole-like endoscopic surgery (ESD) between 206 patients with and without cirrhosis. The goal was to find safer and more effective screening and treatment approaches for this high-risk group.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
endoscopic submucosal dissection (ESD)
What this could lead to
If successful, this could help doctors choose safer and more effective treatment strategies for early-stage upper GI cancer in patients with cirrhosis and varices.
What could go wrong
This is a retrospective study, meaning it looks back at past data, so it cannot prove cause and effect. Results may not apply to all patients, and the small size limits reliability.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Renmin Hospital of Wuhan University

    Wuhan, Hubei, 430000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.